Biocon, Optimer in Pact to Supply, Make Fidaxomicin

Biocon and Optimer Pharmaceuticals said on Monday they have signed a long-term supply agreement to manufacture Fidaxomicin, an antibiotic used to treat clostridium difficile infection.
The Economic Times